Ardelyx reported $5.1M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Amgen USD 3.96B 464M Dec/2025
Ardelyx USD 5.1M 431K Dec/2025
aTyr Pharma USD 24.47M 51.21M Dec/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Curis USD -7.88M 4.63M Dec/2025
Sanofi EUR 1.5B 2.29B Dec/2025
TG Therapeutics USD 50.49M 21.13M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Xoma USD -15.64M 5.56M Sep/2024